- Home
- IH vs ABOS Comparison
IH vs ABOS Comparison
Compare IH & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IH
- ABOS
- Stock Information
- Founded
- IH 1996
- ABOS 1996
- Country
- IH China
- ABOS United States
- Employees
- IH N/A
- ABOS N/A
- Industry
- IH Other Consumer Services
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- IH Real Estate
- ABOS Health Care
- Exchange
- IH Nasdaq
- ABOS Nasdaq
- Market Cap
- IH 96.9M
- ABOS 83.5M
- IPO Year
- IH 2020
- ABOS 2021
- Fundamental
- Price
- IH $1.87
- ABOS $1.39
- Analyst Decision
- IH
- ABOS Strong Buy
- Analyst Count
- IH 0
- ABOS 3
- Target Price
- IH N/A
- ABOS $9.33
- AVG Volume (30 Days)
- IH 63.5K
- ABOS 232.9K
- Earning Date
- IH 03-03-2025
- ABOS 03-25-2025
- Dividend Yield
- IH 4.49%
- ABOS N/A
- EPS Growth
- IH N/A
- ABOS N/A
- EPS
- IH 0.28
- ABOS N/A
- Revenue
- IH $134,002,994.00
- ABOS N/A
- Revenue This Year
- IH $15.90
- ABOS N/A
- Revenue Next Year
- IH $8.64
- ABOS N/A
- P/E Ratio
- IH $6.72
- ABOS N/A
- Revenue Growth
- IH N/A
- ABOS N/A
- 52 Week Low
- IH $1.47
- ABOS $1.28
- 52 Week High
- IH $2.48
- ABOS $5.09
- Technical
- Relative Strength Index (RSI)
- IH 65.13
- ABOS 37.15
- Support Level
- IH $1.83
- ABOS $1.36
- Resistance Level
- IH $1.88
- ABOS $1.52
- Average True Range (ATR)
- IH 0.07
- ABOS 0.08
- MACD
- IH 0.01
- ABOS 0.01
- Stochastic Oscillator
- IH 96.43
- ABOS 40.30
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.